Cargando…
Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel
The coronavirus disease-2019 (COVID-19) pandemic has profoundly changed clinical care and research, including the conduct of clinical trials, and the clinical research ecosystem will need to adapt to this transformed environment. The Heart Failure Academic Research Consortium is a partnership betwee...
Autores principales: | Psotka, Mitchell A., Abraham, William T., Fiuzat, Mona, Filippatos, Gerasimos, Lindenfeld, JoAnn, Ahmad, Tariq, Bhatt, Ankeet S., Carson, Peter E., Cleland, John G.F., Felker, G. Michael, Januzzi, James L., Kitzman, Dalane W., Leifer, Eric S., Lewis, Eldrin F., McMurray, John J.V., Mentz, Robert J., Solomon, Scott D., Stockbridge, Norman, Teerlink, John R., Vaduganathan, Muthiah, Vardeny, Orly, Whellan, David J., Wittes, Janet, Anker, Stefan D., O'Connor, Christopher M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836888/ https://www.ncbi.nlm.nih.gov/pubmed/33183511 http://dx.doi.org/10.1016/j.jacc.2020.09.544 |
Ejemplares similares
-
Impact of the COVID-19 Pandemic on Cardiovascular Health in 2020: JACC State-of-the-Art Review
por: Roth, Gregory A., et al.
Publicado: (2022) -
Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week
por: Sandoval, Yader, et al.
Publicado: (2020) -
Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials
por: Fiuzat, Mona, et al.
Publicado: (2022) -
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review
por: Talasaz, Azita H., et al.
Publicado: (2021) -
Randomized Trials Versus Common Sense and Clinical Observation: JACC Review Topic of the Week
por: Fanaroff, Alexander C., et al.
Publicado: (2020)